Navigation Links
Serum Institute Launches New Tetanus-Diphtheria Vaccine

India's leading vaccine manufacturer Serum Institute of India has manufactured for the first time first indigenous Tetanus and Diphtheria (Td) vaccines // .

The vaccine is called Td-Vac and will combat the deadly diphtheria and tetanus among both adolescents and adults. The new vaccine will replace the existing TT (Tetanus) vaccine, which is normally administered after an injury.

Td-Vac is priced at Rs 7.50 whereas the TT vaccine costs Rs.6.50. Revenues of Rs 5-6 crore is expected at the end of one year. One-lakh ampoules are being launched in the first phase that is worth Rs.60 lakhs. The vaccine is scheduled to be launched by this month end or early January 2006.

Serum Institute of India Marketing Director Masud Ahmed said - "With the launch of India's first indigenous vaccine in this segment, we are yet again offering the Indian masses the benefit of two vaccines in one, as is the norm in developed countries. It puts us on par with their standards,"

"The incidence of Diphtheria has doubled in the last one year and the mortality rate of 20 per cent in India is also very high," he said.

There were other reasons also for the company to launch the vaccine. "The Indian Academy of Pediatrics has recommended the use of Td vaccine in all individuals over the age of seven years," he said.

Chairman Dr Cyrus Poonawalla earlier said the Institute had always looked forward at launching international standard life saving vaccines in the Indian market.

'Health authorities in the Western countries advise the use of Td (Tetanus and Diphtheria) vaccine instead of the TT (Tetanus) vaccine. Now, with the launch of Td-Vac, India's first indigenous Td'vaccine, we are yet again offering the Indian masses the benefit of two vaccines in one, and which is the norm in developed countries' he further added.


Page: 1

Related medicine news :

1. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
2. Relationship Between Serum Dioxin Levels And Age At Menopause
3. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
4. Higher Serum Selenium Linked With Reduced Risks of Prostate Cancer - in Some Men
5. Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men
6. Magsaysay Award for Dr.Shanta from Chennai Cancer Institute
7. Ontario Institute for Cancer Research is funded $142 million
8. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
9. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
10. Georgia Institute of Technology develops doppler Vein finder
11. Germany Institutes Tough Measures To Tackle Bird Flu
Post Your Comments:

(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology: